The University of Chicago Header Logo

Connection

Sonali Smith to Humans

Back to Details
This is a "connection" page, showing publications Sonali Smith has written about Humans.
Sonali Smith
Connection Strength
0.207
Humans
  1. Too much and not enough: revisiting maintenance rituximab in indolent lymphomas. Haematologica. 2022 02 01; 107(2):353-354.
    View in: PubMed
    Score: 0.026
  2. Indolent lymphomas: introduction to a series highlighting progress and ongoing challenges. Haematologica. 2022 01 01; 107(1):4-6.
    View in: PubMed
    Score: 0.026
  3. Safety and tolerability of idelalisib, lenalidomide, and rituximab in relapsed and refractory lymphoma: the Alliance for Clinical Trials in Oncology A051201 and A051202 phase 1 trials. Lancet Haematol. 2017 Apr; 4(4):e176-e182.
    View in: PubMed
    Score: 0.019
  4. New drugs for the treatment of non-Hodgkin lymphomas. Chin Clin Oncol. 2015 Mar; 4(1):14.
    View in: PubMed
    Score: 0.016
  5. The anti-CD80 primatized monoclonal antibody, galiximab, is well-tolerated but has limited activity in relapsed Hodgkin lymphoma: Cancer and Leukemia Group B 50602 (Alliance). Leuk Lymphoma. 2013 Jul; 54(7):1405-10.
    View in: PubMed
    Score: 0.014
  6. Maintenance rituximab revisited: is it worth the cost? Leuk Lymphoma. 2012 Dec; 53(12):2331-2.
    View in: PubMed
    Score: 0.014
  7. Targeting mTOR in mantle cell lymphoma: current and future directions. Best Pract Res Clin Haematol. 2012 Jun; 25(2):175-83.
    View in: PubMed
    Score: 0.014
  8. Temsirolimus has activity in non-mantle cell non-Hodgkin's lymphoma subtypes: The University of Chicago phase II consortium. J Clin Oncol. 2010 Nov 01; 28(31):4740-6.
    View in: PubMed
    Score: 0.012
  9. Recombinant interferon-alpha2b added to oral cyclophosphamide either as induction or maintenance in treatment-naive follicular lymphoma: final analysis of CALGB 8691. Leuk Lymphoma. 2009 Oct; 50(10):1606-17.
    View in: PubMed
    Score: 0.011
  10. Second autologous stem cell transplantation for relapsed lymphoma after a prior autologous transplant. Biol Blood Marrow Transplant. 2008 Aug; 14(8):904-12.
    View in: PubMed
    Score: 0.010
  11. Thalidomide has limited single-agent activity in relapsed or refractory indolent non-Hodgkin lymphomas: a phase II trial of the Cancer and Leukemia Group B. Br J Haematol. 2008 Feb; 140(3):313-9.
    View in: PubMed
    Score: 0.010
  12. Sequential doxorubicin and topotecan in relapsed/refractory aggressive non-Hodgkin's lymphoma: results of CALGB 59906. Leuk Lymphoma. 2006 Aug; 47(8):1511-7.
    View in: PubMed
    Score: 0.009
  13. Reduced-intensity transplantation for lymphoma. Curr Treat Options Oncol. 2006 Jul; 7(4):295-305.
    View in: PubMed
    Score: 0.009
  14. Something old, something new.... Leuk Lymphoma. 2006 Apr; 47(4):576-7.
    View in: PubMed
    Score: 0.009
  15. Nonmyeloablative transplantation for lymphoma. Curr Treat Options Oncol. 2003 Aug; 4(4):261-8.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.